NCT05669950View on ClinicalTrials.gov

A Trial of Lu AG13909 in Participants With Congenital Adrenal Hyperplasia

PHASE1/PHASE2RecruitingINTERVENTIONAL
Enrollment

42

Participants

Timeline

Start Date

December 19, 2022

Primary Completion Date

September 30, 2026

Study Completion Date

December 31, 2027

Conditions
Congenital Adrenal Hyperplasia
Interventions
DRUG

Lu AG13909

Solution for infusion

Trial Locations (7)

2100

RECRUITING

Rigshospitalet, Copenhagen

17174

RECRUITING

Karolinska University Hospital, Stockholm

413 45

RECRUITING

Sahlgrenska University Hospital, Gothenburg

B15 2TH

RECRUITING

NIHR/Wellcome Trust Clinical Research Facility, Birmingham

CB2 0SL

RECRUITING

Cambridge Clinical Research Centre, Cambridge

SE1 9RT

RECRUITING

NIHR Clinical Research Facility, London

W1T 7HA

RECRUITING

University College London Hospital - NIHR, London

All Listed Sponsors
lead

H. Lundbeck A/S

INDUSTRY

NCT05669950 - A Trial of Lu AG13909 in Participants With Congenital Adrenal Hyperplasia | Biotech Hunter | Biotech Hunter